thymoquinone has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapoor, VK; Malik, S; Negi, P; Singh, A | 1 |
| Adalı, F; Bozkurt, MF; Gonul, Y; Kocak, A; Ozdemir, C; Ozkececi, G; Sen, OG; Tunay, K; Yuksel, Y | 1 |
1 review(s) available for thymoquinone and Cardiomyopathies
| Article | Year |
|---|---|
Thymoquinone: A small molecule from nature with high therapeutic potential.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Biological Availability; Breast Neoplasms; Carcinoma, Hepatocellular; Cardiomyopathies; Colonic Neoplasms; Diabetes Mellitus, Type 2; Humans; Liver Neoplasms; Nanoparticle Drug Delivery System; Neoplasms; Nervous System Diseases | 2021 |
1 other study(ies) available for thymoquinone and Cardiomyopathies
| Article | Year |
|---|---|
Effects of thymoquinone against cisplatin-induced cardiac injury in rats.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Benzoquinones; Cardiomyopathies; Cardiotoxicity; Cisplatin; Heart; Immunohistochemistry; Male; Myocardium; Myocytes, Cardiac; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Rats, Wistar; Reference Values; Reproducibility of Results; Time Factors; Treatment Outcome | 2016 |